In probing the cell of origin in malignant B cells, an imprint of somatic hypermutation (SHM) in immunoglobulin (Ig) variable (V) region genes delineates antigen encounter, and identifying the precise pathway generating SHM in the normal B-cell counterpart becomes relevant. SHM remains the definitive memory imprint in normal human B cells, but CD27 expression also delineates memory. Recently, dye extrusion adenosine triphosphate-binding transporter assays identified circulating isotype-switched memory B cells that lacked CD27, yet exhibited low levels of SHM. To extend findings, we report a pre-switched CD27
In probing the cell of origin in malignant B cells, an imprint of somatic hypermutation (SHM) in immunoglobulin (Ig) variable (V) region genes delineates antigen encounter, and identifying the precise pathway generating SHM in the normal B-cell counterpart becomes relevant. SHM remains the definitive memory imprint in normal human B cells, but CD27 expression also delineates memory. Recently, dye extrusion adenosine triphosphate-binding transporter assays identified circulating isotype-switched memory B cells that lacked CD27, yet exhibited low levels of SHM. To extend findings, we report a pre-switched CD27
Àve circulating memory B-cell population in normal blood using comparable assays, and isolated
Àve cells (499% purity) for the analysis of IGHV5/IGHV3-IGHM transcripts. Of these (n ¼ 334), B78% were germ line and naive B cell derived. Strikingly, 21.9% of the transcripts were mutated. They showed 3-5 mutations (13.5% of sequences) and 45 mutations (8.4% of sequences) per transcript. Accrual of mutations in a subset of CD19
Àve cells define a new circulating pre-switched memory B-cell pool, present in substantial numbers in the population harboring naive B cells. These
Introduction
Defining the cell of origin that causes B-cell tumors is a central question in understanding the pathogenesis of malignant B cells. Allied to this are questions of a role for antigen in selecting such a cell, what the nature of antigen might be and whether it is presented in the context of T-cell help or through T-independent pathways. We have been addressing these questions by focusing on the analysis of immunoglobulin (Ig) variable (V) region genes in malignant B cells, as these genes encode the antigen-binding domains of the surface Ig molecule and can reveal important aspects of clonal history of the cell of origin. The most striking aspect is whether such a cell has undergone somatic hypermutation (SHM) in response to antigen, then generating questions of where SHM may have occurred and in response to which stimuli.
In normal B cells, a memory of antigen is imprinted irreversibly by SHM in Ig V genes during T-cell-dependent encounter through germinal centers (GCs) in secondary lymphoid organs. 1 Isotype class switch recombination can also occur in the GCs by deleting specified constant region coding sequences. 1 Although both SHM and class switch recombination have generally been regarded as markers of memory B cells, a seminal finding was the identification of CD27 as an apparently robust phenotypic marker able to discriminate between human naive and memory B cells. 2 The circulating 'classical' CD27 þ memory pool in that study was shown to 2 However, SHM can also occur through T-independent mechanisms ectopically at non-GC sites, 3 and this may impact crucially on deciphering a role for instance, for infection-related antigens in clonal tumor origins.
In malignant B cells, there are instances when the presence of SHM is confounding, as it does not correlate with the expected classical memory phenotype. This is illustrated by hairy cell leukemia (HCL) cells that exhibit mutated IGHV genes but are CD27 Àve . 4, 5 In addition, in IgM-expressing Waldenstrom's macroglobulinemia, mutated tumor cells are seen in CD27 Àve fractions, 6, 7 and it has been proposed that origins of this disease may be from 'unusual' memory B cells. 6 Interestingly, more recent observations indicate that the normal human B-cell memory pool may as yet not be mapped fully. These studies have examined the association of CD27 expression as an absolute requirement in normal human memory B cells. Pivotal to the studies is an assay based on dye extrusion by the adenosine triphosphate-binding cassette subfamily B1 (ABCB1) transporter pump, which is functionally restricted to naive B cells. 8 When loaded with a suitable dye, ABCB1-positive naive B cells extrude the dye and retain a low level of dye fluorescence, whereas CD27 þ memory B cells are pump negative and retain much higher levels of dye. 8 Using this assay, a population of IgG þ but CD27 Àve B cells could be identified as ABCB1-negative in normal human blood lymphocytes. A subset of this ABCB1
Àve IgG þ CD27 Àve population was indeed shown to be functionally comparable with IgG þ CD27 þ memory B cells. 8 It is noteworthy that these IgG þ CD27 Àve cells were not initially examined for V gene mutations. However, two parallel studies established that the new memory IgG þ CD27
Àve population indeed displayed SHM, but at a lower level than did classical switched memory B cells. 9, 10 A relevance for these IgG þ CD27 Àve cells also emerged in B-cell disease, specifically for systemic lupus erythematosus in which they represent a major circulating compartment. 10 As yet, however, it is not known whether a pre-switched CD27
Àve component also exists in the normal human circulation, with a parallel mutational imprint. This is of relevance for understanding the CD27
Àve memory B-cell pool more fully as well as for defining origins of B cells in malignancy. In this study, we report the IGHV mutational status
Àve cells in normal circulating B lymphocytes.
Materials and methods

Analysis and isolation of circulating B lymphocytes by flow cytometry procedures
Peripheral blood mononuclear cells were isolated from healthy donors after obtaining informed consent using Lymphoprep (Axis Shield, Bicton Industrial Park, UK), and were analyzed and cell sorted by flow cytometry using a FACSAria (BD Biosciences, Oxford, UK). The two donors for cell sorted fractions for molecular analysis were aged 23 and 36 years, respectively.
For flow cytometry, 2-4 Â 10 7 peripheral blood mononuclear cells were incubated with a-CD19-perCP-cy5.5 at 1:10 (BD Pharmingen, Oxford, UK), a-IgM-phycoerythrin (PE) at 10 mg/ml (Dako, Ely, UK), a-IgD-FITC (a-IgD-fluorescein isothiocyanate) at 16 mg/ml (Dako) and a-CD27-allophycocyanin (APC) at 1:10 (Biolegend, San Diego, CA, USA), or with relevant isotype antibody controls in FACS buffer (1% bovine serum albumin, 4 mM EDTA (ethylenediaminetetraacetic acid) and 0.15 mM sodium azide in phosphate-buffered saline) for 30 min at 4 1C. Isotype antibody control labeling was performed with mIgG 1 ,kperCP-cy5.5 (BD, Pharmingen), mIgG 1 ,k-APC (BD, Pharmingen), rF(ab) 2 
) populations were harvested for RNA extraction. Amplification of IGHV-IGHM gene transcripts, detailed below, then confined our analysis to CD19
þ IgM þ cells within the CD27/IgD-sorted populations. Donor T cells (2 Â 10 6 ) were isolated for genomic DNA analysis using a-CD19-perCP-cy5.5 (BD) and a-CD3-PE (BD) at 1:10 and cell sorted as a CD19
Àve
CD3
þ fraction, with isotype controls mIgG 1 , k-perCP-cy5.5 and mIgG 1 , k-PE (BD) used at appropriate concentrations.
ABCB1 transporter assay
The ABCB1 transporter assay was based on the use of the Mitotracker Green-FM dye (MTG; Invitrogen, Paisley, UK). Approximately 1 Â 10 7 peripheral blood mononuclear cells were incubated in medium with 100 nM MTG at 37 1C for 30 min in the presence or absence of 10 nM ABCB1 transporter inhibitor, PGP-4008 (Alexis, Lausen, Switzerland), followed by a 2-h chase in medium alone. Cells were then washed in the FACS buffer before staining with a-IgM-biotin at 50 mg/ml (Southern Biotech, Birmingham, AL, USA) at 4 1C for 30 min. A further wash in the FACS buffer preceded staining with a-CD19-Pacific Blue at 1:50 (BD), a-CD27-APC at 1:10 (Biolegend), a-IgD-PE at 5 mg/ml (Dako) and streptavidin-perCP-cy5.5 at 2 mg/ml (BD) at 4 1C for 30 min. Isotype antibody control labeling was performed as described above. Separation of both ABCB1-positive and ABCB1-negative cells was established using the ABCB1 transporter inhibitor. As MTG was never entirely extruded from cells, MTG-stained cells were spiked with unstained cells to confirm the correct acquisition voltage.
CD19
þ IgM þ D þ cells were then analyzed by MTG retention and CD27 expression as reported. 8 Isolation of RNA and DNA for IGHV analysis
þ populations were used for RNA extraction using the RNeasy Mini Kit (Qiagen, Crawley, UK), and cDNA was synthesized using SuperScript II Reverse Transcriptase (Invitrogen), both in accordance with the manufacturers' instructions. Using cDNA, IGHM transcripts were specifically amplified with downstream Cm primers. IGHV5-IGHM gene transcripts were amplified from sorted
þ fractions by semi-nested reverse transcriptase-PCR, using in the first round a combination of IGHV5 leader (5 0 -atggggtcaaccgccatcctcg) or IGHV3 leader (5 0 -ccatg gagtttgggctgagctgg) primers, respectively, with downstream IGHM100 3 0 (5 0 -ggagaaagtgatggagtcgg), followed in the second round of amplification by IGHV5 framework-1 (5 0 -gaggtg cagctgngtcagtctg) or IGHV3 framework-1 (5 0 -gaggtgcagctggtg sagtcyg) with IGHM100 as previously described. 4, 7, 11 PCR products were cloned and individual plasmids with IGHV-IGHM inserts were sequenced as described. 4, 7, 11 Taq error was calculated in a 350-400 bp stretch of the IGHM constant region (excluding primer sequences) using semi-nested IGHV5 or IGHV3 upstream primers, as described above, with IGHM370 
CD3
þ T cells using the QIAamp DNA Blood Mini Kit (Qiagen), according to the manufacturer's instructions. The germline IGHV5 gene segment was amplified using IGHV5-leader and 3 0 recombination site-specific primers (5 0 -tcggggctggtttctctcactgtg, 5 0 -ggctcg gggctggtttctctcact) before cloning and analysis.
Results
To examine the nature of IgM
Àve cells, two separate investigations were undertaken. First, we used a MTG dye extrusion assay to seek evidence for ABCB1 pump-negative putative CD27
Àve memory B cells. Second, we isolated
Àve cells to virtual purity to allow a molecular analysis of IGHV genes, in the absence of any dye use during isolation.
To facilitate the use of the MTG dye, the extrusion assay was optimized as reported to distinguish between naive and memory B cells in normal lymphocytes.
8 CD19 þ -gated B cells incubated with MTG comprised a mixture of cells able to extrude and retain dye (Figure 1a ; top panel). These two populations were separable using the ABC-transporter inhibitor PGP-4008 ( Figure 1a ; middle panel), in which high fluorescence indicates retention of dye as cells are ABCB1
Àve . These ABCB1 Àve cells,
as defined by Lanzavecchia's laboratory, 8 consist of transitional and memory B cells. Inclusion of unstained cells with MTGlabeled cells showed that ABCB1 þ cells do retain a low level of dye despite efflux (Figure 1a ; lower panel), and this would be a limiting factor in obtaining highly pure populations of cells if a panel of markers is used that include dye. Focusing on CD19 (Figure 1b) , we evaluated MTG retention in both CD27
Àve and CD27 þ populations (Figure 1c) . Notably, we identified a subset of IgM þ D þ CD27 Àve cells that was ABCB1
Àve in 4/4 healthy individuals, suggestive of a new potential memory population (Figure 1c ). This subset comprised 18.9 ( ± 2.6 s.d.)% of the CD19
Àve B cells, in contrast, were ABCB1 þ as reported (Figure 1c) . 8 To (Figure 2a-c) . (Figure 2c) .
Àve fractions were harvested by highresolution cell sorting (Figure 2d) . Potential contamination by CD19 þ CD27 þ B cells was o0.4% when CD27 Àve cells were re-sorted to check purity (Figure 2d ; bottom right-hand quadrant). Populations of CD19
þ IgM þ /Àve CD27 þ cells comprising conventional memory cells were also purified for IGHV gene comparisons (Figure 2c) . The molecular analysis of IGHV genes in sorted fractions focused entirely on IGHM transcripts. In the
Àve fraction, these transcripts are derived from IgM þ D þ B cells, whereas in the combined CD27 þ comparator fractions, Cm transcripts are derived either from
We examined IGHV5 and IGHV3 genes to probe the smallest (HV5) and largest (HV3) families to obtain a representative view of repertoire use. As these fractions contain mature B cells, mRNA levels encoding
Àve B cells include ABCB1 transporter-negative cells that retain high levels of Mitotracker green-FM (MTG) dye, revealing a potential memory B-cell pool. MTG dye readily permeates B cells and is only extruded by naive B cells which express the ABCB1 transporter, whereas memory B cells lacking ABCB1 transporter activity retain dye and exhibit high fluorescence. 7 MTG permeates all cells and is then specifically extruded to give a broad spectrum of fluorescence (a, top-most profile), and when coupled with the use of the ABCB1 transporter inhibitor PGP-4008, allowed gating to separate ABCB1 þ B cells which expel dye and ABCB1
Àve B cells which retain dye (panel a, middle profile), and spiking with unstained cells confirmed a dye-related gating (panel a, bottom profile).
B cells (c, bottom right and left quadrants). The potential memory B-cell subset delineated by ABCB1
Àve expression is clearly visible (panel c, bottom right quadrant): percentages are from a representative individual normal donor, and overall (n ¼ 4) this subset was 18.9 (±2.6)%.
IGHV rearrangements are comparable between cells, and do not bias cloning analysis. Only individual potentially functionally rearrangements with distinct CDR3 domains were included in the analysis, and rare repeat sequences were excluded. Importantly, to assess Taq error rate accurately, we simultaneously examined a 350-400 bp region of the Cm constant region by nested reverse transcriptase-PCR followed by cloning and sequence analysis using the same cDNA as used for IGHV analysis from each fraction. Data are based on pooled sequences from replicate nested PCRs.
From two donors, we analyzed IGHV5-IGHM (n ¼ 191) and
Àve fractions, and compared their mutational imprints with IGHV5-IGHM (n ¼ 113) and IGHV3-IGHM (n ¼ 74)
þ memory B cells. Analysis of individual donors yielded very similar data, and pooled data sets are shown (Figures 3 and 4) .
Àve populations, 12% of IGHV5-IGHM transcripts exhibited 3-5 mutations in potentially functional V(D)J sequences and 7.9% displayed 45 mutations (Figure 3a) . The frequency of 3-5 mutations was sixfold higher than observed in the 'control' Cm region transcripts (2%; n ¼ 101), analyzed in parallel in this population to assess Taq error. Only a maximum of three mutations per Cm region were observed, and more than five mutations were never seen in these 'control' Cm sequences (Figures 3a and b) . The remainder
Àve transcripts (B78%) revealed unmutated 100% germline IGHV genes (data not shown), reflecting naive B-cell derivation, and confirming a very low Taq error rate. In donor 1, we also tracked the germline IGHV5 gene using genomic DNA from T cells and specific primers flanking the gene segment, and identified the same allele as determined by IMGT database alignment (data not shown). This verified that the low level of mutation seen in IGHV5 was not caused by polymorphic variation. In comparison, of the IGHV5-IGHM transcripts from conventional IgM þ D þ /Àve CD27 þ memory B cells, 20.4% displayed 3-5 mutations and 54.9% with 45 mutations (Figure 3a ) (remaining 24.7% transcripts displaying o3 mutations; data not shown). IGHV3 family gene usage is most frequent in the normal B-cell repertoire, and was also assessed for mutations and gene segment use in the CD19
Àve pool. Of the IGHV3-IGHM transcripts described in this study, 15.4% displayed 3-5 mutations, and 9.1% 45 mutations (Figure 3b) . In CD27 þ B cells, 9.5% displayed 3-5 mutations and 79.7%
45 mutations (Figure 3b ). Taken together, of IGHV5-IGHM and (Figure 3c ). These data reveal a CD19
Àve subset with a mutated memory imprint.
The level of mutation in Cm transcripts was compared in the CD27
Àve versus CD27 þ cells obtained from the same donor population (Figure 4) . The frequency of CD27
Àve transcripts exhibiting between 16 and 20 mutations decreased markedly, and there were no CD27
Àve transcripts that displayed 420 mutations, a level of mutation restricted solely to CD27 þ cells (Figure 4a) . Similarly, the number of transcripts displaying 16-20 and 420 mutations diminished substantially in the study of IgG þ CD27 Àve memory B cells, whereas the 420 level of mutation was highly prevalent in classical switched CD27 þ B cells. 9, 10 Consequently, a restricted level of IGHV mutation appears to be a parallel feature in both pre-switched and switched subsets of CD27
Àve memory B cells. Patterns of IGHV3 family gene segment use were similar in IgM-expressing cells derived from the 
Discussion
Our observations show a new circulating subset of
Àve cells which are memory B cells by IGHV gene mutational status, the 'gold standard,' existing at a frequency of B20% in a population previously regarded as entirely composed of naive B cells. The identification of circulating mutated IgM þ D þ CD27 Àve B cells extends the repertoire of unusual memory B cells which include isotypeswitched mutated CD27
Àve B cells in the normal periphery, 9, 10 and taken together, suggests distinctive origins and functions. As yet, the source of these CD27 Àve memory B cells is unknown. Interestingly, there are CD27 Àve -mutated B-cell subsets that are tissue localized, but their relationship to the circulating memory CD27
Àve B lymphocytes is currently obscure. The tissue-localized subsets may differ. IgD þ CD27
Àve
CD38
Àve 'pro/pre-GC' B cells exist as a tonsillar 
FcRH4
þ B cells with a comparably low level of mutation have also been described in the tonsil, but these remain tissue localized and are not observed in the blood. 15 FcRH4, Fc receptor homolog 4, is a immunoregulatory molecule, 15 and based on these observations seemed to be a relevant marker for mutated CD27
Àve cells. However, normal circulating IgG þ CD27 Àve memory B cells lack FcRH4 expression, 10 indicating divergent origins from the tonsillar B-cell subset. Lymph nodes also harbor a predominantly isotype-switched CD27
Àve pool of large inter-follicular B cells, but in marked contrast, these nodal B cells are extensively mutated. 16 It seems then that multiple pathways generate a repertoire of CD27 Àve memory B cells at different sites, with as yet unknown functions.
It is worth noting that even in relation to conventional mutated IgM þ D þ CD27 þ cells, the precise pathway(s) of their origins is by no means fully ascertained. Although early observations suggested that IgM þ D þ CD27 þ are GC-derived B cells, it has also been argued that they are generated in the pre-immune repertoire in the marginal zone. 17 However, more recent experiments in which human hematopoietic stem cells have been grafted in immunodeficient mice reveal an induction Àve transcripts revealing this level of mutation than CD27 þ transcripts. This is more marked when evaluating 420 mutations, a level of mutation not observed in any CD27
Àve transcript but displayed by 5.8% of CD27 þ sequences. To examine the repertoire of B cells recruited into the CD27 Àve/ þ memory pools, IGHV3 family gene segments were evaluated (b), revealing a comparable repertoire of gene segment usage in both subsets. 
þ subsets. The data shows the frequency of transcripts (%/all sequences analyzed) revealing stated number of mutations, first in IGHV5-IGHM in respective populations (a), next in IGHV3-IGHM sequences (b) and then as combined (IGHV5 þ IGHV3)-IGHV sequences (c). PCR error was assessed in the
Àve B-cell population by amplifying a 350-400 bp constant region of the Cm transcripts, a region known not to be targeted by SHM, and herein, a very low number of transcripts displaying Taq error nucleotide changes (3-5 range) were identified (2.0% of 101 sequences analyzed) (panels a-c). In these 'control' Cm region transcripts, only a maximum of 3 nucleotide errors per transcript were observed, and 45 changes resulting from Taq mistakes were never observed.
þ B cells in a T-cell-independent manner, but appear to exclude marginal zone origins. 18 Nevertheless, these observations suggest that separate pathways could lead to pre-switched CD27 þ memory B cells and isotypeswitched CD27 þ cells. In speculating, this bifurcation may also hold for both the pre-switched and the switched CD27 Àve memory pool.
The lower level of mutation seen in both pre-and postswitched CD27
Àve B cells argues for a common mechanism. It is evident that CD27-CD70 interactions are not required to mediate SHM in these CD27
Àve cells. This suggests either non-GC sites of mutational activity, such as those that generate a low level of SHM activity in response to T-independent antigens, 3 or that CD27 Àve memory cells may in fact represent early émigrés from GC-initiated events, as postulated for IgG þ CD27 Àve memory B cells. 9 These possibilities remain unresolved, but the precise tissue site(s) will have relevance for dissecting a role in disease.
This study has implications for understanding origins of malignant B cells, and in particular, for HCL. We had previously shown that IgM-expressing HCL displayed mutated IGHV genes yet lacked CD27, and frequently co-expressed multiple switched isotypes (mult-HCL). 4, 5, 11 Our large cohort study had shown that mult-HCLs comprised the major subset of disease, as compared with single isotype-expressing HCL. 4 It is conceivable that IgM-co-expressing mult-HCL derives from the novel mutated IgM þ D þ CD27 Àve B cells described in this study. mult-HCL tumor cells also initiate atypical switch events, which seem to exclude deletional class switch recombination and generate variant isotype transcripts most likely through RNA processing.
11
In single isotype-expressing HCL expressing only IgG, origins from IgG þ CD27 Àve cells are also plausible. 9, 10 Ongoing mutational activity targeting IGHV in HCL is also a recurrent feature of leukemic cells, in which AID transcripts are constitutively expressed, 11 and may lead to the accrual of higher levels of mutations observed in this tumor.
4,11
IGHV-mutated CD27
Àve cells also comprise part of the tumor clone in Waldenstrom's macroglobulinemia, 6, 7 but here it is unknown whether malignant cells derive from unusual
Àve memory B cells that we describe herein or from conventional CD27 þ memory B cells that subsequently lose CD27 expression. If the latter, it will then also be relevant to know whether IgM þ D þ CD27 þ -mutated B cells are GC-or non-GC-derived in defining origins of Waldenstrom's macroglobulinemia.
In conclusion, delineating a new IgM þ D þ CD27 Àve circulating memory B-cell population has relevance to understanding origins of B cells in health and disease.
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